Johnson & Johnson in Talks to Reduce $1.5 Billion Elan Corporation PLC Deal Price According to Source
Reuters -- U.S. health-care firm Johnson & Johnson is in talks to cut the price of a $1.5 billion deal with Irish drugmaker Elan Corp, a source familiar with the negotiations said on Sunday.